Vimarsana
Biggest News Aggregation in the World

Page 2 - Defiance Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Defiance Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Defiance Study Today - Breaking & Trending Today

Leap Therapeutics Reports Second Quarter 2022 Financial Results - Vimarsana News

Leap Therapeutics Reports Second Quarter 2022 Financial Results

Published: August 14, 2022

/PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomNew ZealandMatthew DeyoungDouglase OnsiAmerican Society Of Clinical OncologyPrnewswire Leap Therapeutics IncSecurities ExchangeBeigene LtdLeap Therapeutics IncUniversity Of Alabama At BirminghamCancer CenterClinical OncologyChief Executive OfficerBeigene Announced InitiationOngoing Distinguish StudyAnnounced InitiationDefiance StudySecond Line PatientsInvestigator Initiated TrialEndometrial CancerPresented Initial Clinical DataInvestigator Sponsored StudyProstate CancerSecond Quarter
Leap Therapeutics Reports Second Quarter 2022 Financial Results - Vimarsana News

Leap Therapeutics Reports Second Quarter 2022 Financial Results

Published: August 12, 2022

/PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomNew ZealandMatthew DeyoungDouglase OnsiAmerican Society Of Clinical OncologyPrnewswire Leap Therapeutics IncSecurities ExchangeBeigene LtdLeap Therapeutics IncUniversity Of Alabama At BirminghamCancer CenterClinical OncologyChief Executive OfficerBeigene Announced InitiationOngoing Distinguish StudyAnnounced InitiationDefiance StudySecond Line PatientsInvestigator Initiated TrialEndometrial CancerPresented Initial Clinical DataInvestigator Sponsored StudyProstate CancerSecond Quarter